HighTower Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$253K Buy
9,554
+73
+0.8% +$1.93K ﹤0.01% 3063
2025
Q1
$229K Buy
9,481
+4,020
+74% +$97.1K ﹤0.01% 3057
2024
Q4
$220K Sell
5,461
-2,521
-32% -$101K ﹤0.01% 3101
2024
Q3
$507K Buy
7,982
+3,247
+69% +$206K ﹤0.01% 2388
2024
Q2
$251K Sell
4,735
-383
-7% -$20.3K ﹤0.01% 2852
2024
Q1
$419K Buy
+5,118
New +$419K ﹤0.01% 2395
2021
Q4
Sell
-11,561
Closed -$72K 3159
2021
Q3
$72K Sell
11,561
-120
-1% -$747 ﹤0.01% 2865
2021
Q2
$71K Buy
11,681
+882
+8% +$5.36K ﹤0.01% 2818
2021
Q1
$68K Buy
+10,799
New +$68K ﹤0.01% 2760
2020
Q4
Sell
-10,601
Closed -$62K 2558
2020
Q3
$62K Sell
10,601
-929
-8% -$5.43K ﹤0.01% 2244
2020
Q2
$83K Buy
11,530
+1,804
+19% +$13K ﹤0.01% 2112
2020
Q1
$44K Buy
+9,726
New +$44K ﹤0.01% 1986
2019
Q2
Sell
-21,848
Closed -$217K 2348
2019
Q1
$217K Hold
21,848
﹤0.01% 1901
2018
Q4
$167K Buy
21,848
+2,012
+10% +$15.4K ﹤0.01% 1878
2018
Q3
$344K Buy
+19,836
New +$344K ﹤0.01% 1656